ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ANIP | AMGN | GILD | CELG | VRTX |
| Company | ANI Pharma Inc | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 67.39 | 310.88 | 64.78 | 108.01 | 402.77 |
| High | 67.90 | 312.73 | 65.56 | 108.59 | 407.59 |
| Low | 67.03 | 297.52 | 64.34 | 107.27 | 401.02 |
| Last | 67.36 | 299.48 | 65.54 | 108.24 | 402.50 |
| Change | +0.11 | -11.81 | +0.76 | +0.11 | +1.42 |
| % Change | +0.16% | -3.79% | +1.17% | +0.10% | +0.35% |
| Volume | 116,700 | 4,717,600 | 7,187,200 | 191,230,496 | 1,463,600 |
| 20-Day Average Volume | 118,075 | 2,791,225 | 7,536,365 | 16,188,930 | 1,058,185 |
| Previous Close | 67.25 | 311.29 | 64.78 | 108.13 | 401.08 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 66.18 | 273.78 | 66.69 | 108.17 | 398.34 |
| 20-Day Raw Stochastic | 79.60% | 62.66% | 21.53% | 63.25% | 69.30% |
| 20-Day Relative Strength | 57.42% | 62.69% | 34.71% | 64.69% | 48.38% |
| Weighted Alpha | +55.29 | +27.63 | -20.00 | +46.30 | +14.91 |
| Today's Opinion | 72% Buy | 24% Buy | 100% Sell | 100% Buy | 8% Buy |
| Previous Opinion | 72% Buy | 24% Buy | 100% Sell | 100% Buy | 8% Buy |
| Last Month's Opinion | 88% Buy | 8% Sell | 100% Sell | 100% Buy | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.84% since 04/29/24 | +8.36% since 04/29/24 | -0.61% since 04/29/24 | -1.97% since 11/13/19 | +1.59% since 04/29/24 |
| Low | 64.92 on 04/30/24 | 272.35 on 04/30/24 | 64.33 on 05/03/24 | 107.27 on 11/20/19 | 391.70 on 04/30/24 |
| High | 67.93 on 05/03/24 | 322.60 on 05/03/24 | 65.89 on 05/01/24 | 110.53 on 11/14/19 | 407.59 on 05/06/24 |
| 1-Month | |||||
| %Chg | -0.43% since 04/05/24 | +10.94% since 04/05/24 | -5.81% since 04/05/24 | +5.14% since 10/18/19 | -1.03% since 04/05/24 |
| Low | 64.20 on 04/19/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 102.40 on 10/21/19 | 391.01 on 04/18/24 |
| High | 68.39 on 04/08/24 | 322.60 on 05/03/24 | 69.95 on 04/09/24 | 110.70 on 11/13/19 | 407.59 on 05/06/24 |
| 3-Month | |||||
| %Chg | +18.45% since 02/06/24 | -5.25% since 02/06/24 | -15.67% since 02/06/24 | +13.63% since 08/20/19 | -3.28% since 02/06/24 |
| Low | 54.62 on 02/13/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 93.41 on 08/23/19 | 391.01 on 04/18/24 |
| High | 70.81 on 03/25/24 | 322.60 on 05/03/24 | 76.45 on 02/07/24 | 110.70 on 11/13/19 | 437.00 on 02/27/24 |
| 6-Month | |||||
| %Chg | +7.01% since 11/06/23 | +9.77% since 11/06/23 | -19.23% since 11/06/23 | +14.14% since 05/20/19 | +4.34% since 11/06/23 |
| Low | 48.20 on 12/08/23 | 260.52 on 11/21/23 | 64.33 on 05/03/24 | 89.08 on 07/23/19 | 341.90 on 11/16/23 |
| High | 70.81 on 03/25/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,419,882 | 160,633,888 | 81,602,352 | 77,035,920 | 104,029,752 |
| Shares Outstanding, K | 21,079 | 536,376 | 1,245,077 | 711,714 | 258,459 |
| Annual Sales | 486,820,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 9,869,200,000 |
| Annual Net Income | 18,780,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | 3,619,600,000 |
| Last Quarter Sales | 131,650,000 | 7,447,000,000 | 6,686,000,000 | 4,520,000,000 | 2,517,700,000 |
| Last Quarter Net Income | 1,160,000 | -113,000,000 | -4,170,000,000 | 1,691,000,000 | 968,800,000 |
| 60-Month Beta | 0.80 | 0.60 | 0.22 | 1.41 | 0.39 |
| Per-Share Information | |||||
| Most Recent Earnings | 1.00 on 02/29/24 | 3.96 on 05/02/24 | -1.32 on 04/25/24 | 2.99 on 10/31/19 | 4.76 on 05/06/24 |
| Latest Earnings Date | 05/10/24 | 05/02/24 | 04/25/24 | 10/31/19 | 05/06/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 06/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 17.42 | 16.71 | 16.07 | 10.99 | 29.84 |